BAGALONI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 1.517
EU - Europa 830
AS - Asia 542
SA - Sud America 70
AF - Africa 15
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.988
Nazione #
US - Stati Uniti d'America 1.489
CN - Cina 245
IT - Italia 201
SG - Singapore 151
GB - Regno Unito 138
UA - Ucraina 105
RU - Federazione Russa 99
SE - Svezia 90
BR - Brasile 55
DE - Germania 54
TR - Turchia 54
FR - Francia 44
VN - Vietnam 33
FI - Finlandia 31
IE - Irlanda 27
CA - Canada 14
IN - India 11
MX - Messico 11
AU - Australia 10
ES - Italia 8
ZA - Sudafrica 8
JP - Giappone 7
NL - Olanda 7
AR - Argentina 6
KR - Corea 6
PL - Polonia 6
BD - Bangladesh 4
BE - Belgio 4
EG - Egitto 4
HK - Hong Kong 4
IQ - Iraq 4
IR - Iran 4
AT - Austria 3
EC - Ecuador 3
LK - Sri Lanka 3
LT - Lituania 3
BH - Bahrain 2
EU - Europa 2
ID - Indonesia 2
PK - Pakistan 2
SA - Arabia Saudita 2
UY - Uruguay 2
VE - Venezuela 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
SI - Slovenia 1
TN - Tunisia 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.988
Città #
Ashburn 196
Fairfield 173
Woodbridge 141
Southend 109
Houston 94
Singapore 88
Cambridge 83
Ann Arbor 82
Seattle 77
Jacksonville 75
Wilmington 63
Chandler 46
Beijing 44
New York 41
Dallas 36
Nanjing 35
Urbino 30
Izmir 29
Boardman 28
Los Angeles 23
Dublin 22
Bremen 15
Düsseldorf 15
Helsinki 15
Ho Chi Minh City 15
Princeton 15
Hebei 14
Dearborn 12
Moscow 12
San Francisco 11
Tianjin 11
Chicago 10
Santa Clara 10
Shenyang 10
San Diego 9
Guangzhou 8
Redwood City 8
São Paulo 8
Vittuone 8
Brooklyn 7
Changsha 7
Frankfurt am Main 7
Istanbul 7
Jiaxing 7
Jinan 7
Johannesburg 7
Kocaeli 7
London 7
Pontedera 7
Rome 7
Sydney 7
Atlanta 6
Bisceglie 6
Boston 6
Hanoi 6
Milan 6
Nanchang 6
Nuremberg 6
Tokyo 6
Toronto 6
Cagliari 5
Denver 5
Montreal 5
Ankara 4
Brussels 4
Hong Kong 4
Kunming 4
Lappeenranta 4
Leawood 4
Menlo Park 4
Poplar 4
Portland 4
Redondo Beach 4
Rimini 4
San Mateo 4
Seongnam 4
Turku 4
Augusta 3
Buffalo 3
Cairo 3
Canberra 3
Colombo 3
Des Moines 3
Elk Grove Village 3
Gurgaon 3
Lauterbourg 3
Lecce 3
Mexico City 3
Ningbo 3
Querétaro 3
Quito 3
Shanghai 3
Strasbourg 3
Sulaymaniyah 3
Acton 2
Ardabil 2
Barnala 2
Bologna 2
Columbus 2
Corrientes 2
Totale 1.993
Nome #
XRCC1 399GG genotype predicts significantly longer overall survival in resistant lymphoma patients treated with Benda-EAM and ASCT 295
Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in Malignant Pleural Mesothelioma (MPM) cells. 278
DNA demethylating antineoplastic strategies: a comparative point of view. 240
Premature senescence induced by DNA demethylating agent (Decitabine) as therapeutic option for malignant pleural mesothelioma. 230
Malten, a new synthetic molecule showing in vitro antiproliferative activity against tumor cells and induction of complex DNA structural alterations. 210
Sex-Related Differences in Impact On Safety Of Pharmacogenetic Profile For Colon Cancer Patients Treated With FOLFOX-4 or XELOX Adjuvant Chemotherapy 196
TP53 mutation analysis in gastric cancer and clinical outcomes of patients with metastatic disease treated with Ramucirumab-Paclitaxel or standard chemotherapy 186
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomized, phase III adjuvant TOSCA trial in high-risk colon cancer patients. 180
Patients treated with FOLFOX-4 or XELOX chemotherapy with high-risk stage II and III colon cancer (TOSCA trial): a different impact of pharmacogenetic profile on toxicity in women and men 164
Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib 146
TP53 mutation analysis in gastric cancer and clinical outcomes of patients with metastatic disease treated with antiangiogenic or standard chemotherapy regimens 138
POLYMORPHISMS IN MULTIDRUG RESISTANCE TRANSPORTER GENES MAY AFFECT THE LOSS OF MOLECULAR RESPONSE TO NILOTINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS 134
Glycolytic competence in gastric adenocarcinomas negatively impacts on survival outcomes of patients treated with salvage paclitaxel-ramucirumab. 124
A pharmacogenetic study for clinical outcomes of high-risk stage II and stage III colon cancer patients Treated with oxaliplatin and fluoropyrimidines adjuvant chemotherapy 117
Warburg effect and tp53 mutational status in gastric cancer patients under ramucirumab-based therapy 113
Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma 113
POLYMORPHISMS IN MULTIDRUG RESISTANCE TRANSPORTER GENES AFFECT THE DURATION OF MOLECULAR RESPONSE TO NILOTINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS 101
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy 86
Totale 3.051
Categoria #
all - tutte 12.234
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.234


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021269 0 0 0 0 0 29 66 19 40 28 75 12
2021/2022281 33 15 13 63 9 14 9 32 15 10 22 46
2022/2023218 43 11 11 16 23 39 4 10 39 4 9 9
2023/2024147 13 10 4 11 12 44 4 8 0 20 4 17
2024/2025402 18 10 74 23 18 25 93 15 15 45 54 12
2025/2026558 120 70 89 192 84 3 0 0 0 0 0 0
Totale 3.051